422 Antimicrobial Susceptibility Profiles of Key Blood and Respiratory Bacterial Isolates from Africa and the Middle East

par Renteria, Martha, Sahm, Dan, Leister-Tebbe, Heidi
Publié dans Open Forum Infect Dis (2014)

Tigecycline Susceptibility Trends Among Pathogens Isolated from Complicated Skin and Soft-Tissue Infections in North and Latin America: 2012–2016

par Hoban, Daryl, Renteria, Martha, Leister-Tebbe, Heidi, Sahm, Dan
Publié dans Open Forum Infect Dis (2017)

424 Characterization and Profiling of Multi-Drug Resistant (MDR) Enterobacteriaceae From Latin America

par Renteria, Martha, Sahm, Dan, Bouchillon, Samuel, Leister-Tebbe, Heidi
Publié dans Open Forum Infect Dis (2014)

412 In vitro Activity of Key Antimicrobial Agents Against Bacterial Isolates From Intra-abdominal (IAI) and Skin and Wound (SW) Infections: Europe 2004-2013

par Hoban, Daryl, Bouchillon, Samuel, Badal, Robert, Sahm, Dan, Leister-Tebbe, Heidi
Publié dans Open Forum Infect Dis (2014)

413 In Vitro Activity of Tigecycline against Commonly-Isolated Pathogens of Skin and Skin Structure Infections in the United States – TEST 2011-2013

par Hackel, Meredith, Lob, Sibylle, Bouchillon, Samuel, Sahm, Dan, Hoban, Daryl, Leister-Tebbe, Heidi
Publié dans Open Forum Infect Dis (2014)

418 Antimicrobial Profile of Enterobacteriaceae from North America from 2013

par Johnson, Brian, Johnson, Jack, Bouchillon, Samuel, Hoban, Daryl, Hackel, Meredith, Lob, Sibylle, Biedenbach, Douglas, Leister-Tebbe, Heidi
Publié dans Open Forum Infect Dis (2014)

421 Activity of Tigecycline and Comparators Against Lower Respiratory Tract (LRT) Isolates of Enterobacteriaceae from North America and Europe: 2009-2013

par Hoban, Daryl, Bouchillon, Samuel, Hackel, Meredith, Johnson, Brian, Badal, Robert, Johnson, Jack, Hawser, Stephen, Leister-Tebbe, Heidi
Publié dans Open Forum Infect Dis (2014)

The use of extrapolation based on modeling and simulation to support high‐dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft‐tissue infection...

par Chan, Phylinda L.S., McFadyen, Lynn, Quaye, Andrea, Leister‐Tebbe, Heidi, Hendrick, Victoria M., Hammond, Jennifer, Raber, Susan
Publié dans CPT Pharmacometrics Syst Pharmacol (2021)

Safety and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children

par Roilides, Emmanuel, Carlesse, Fabianne, Leister-Tebbe, Heidi, Conte, Umberto, Yan, Jean Li, Liu, Ping, Tawadrous, Margaret, Aram, Jalal, Queiroz-Telles, Flavio
Publié dans Open Forum Infect Dis (2017)

Population Analysis of Anidulafungin in Infants to Older Adults With Confirmed or Suspected Invasive Candidiasis

par Xie, Rujia, McFadyen, Lynn, Raber, Susan, Swanson, Robert, Tawadrous, Margaret, Leister‐Tebbe, Heidi, Cohen‐Wolkowiez, Michael, Benjamin, Daniel K., Liu, Ping
Publié dans Clin Pharmacol Ther (2020)

Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia

par Roilides, Emmanuel, Carlesse, Fabianne, Tawadrous, Margaret, Leister-Tebbe, Heidi, Conte, Umberto, Raber, Susan, Swanson, Robert, Yan, Jean L., Aram, Jalal A., Queiroz-Telles, Flavio
Publié dans Pediatr Infect Dis J (2020)